Scientists at the Norwegian Defence Research Establishment (Kjeller, Norway) are working in collaboration with the University of Oslo (Oslo, Norway) to develop new methods to detect the illicit use of nerve agents. In a recent study published in the journal Analytical Chemistry, the team presented a novel method for the quantification of nerve agent metabolites in human serum and urine by combining salting-out assisted liquid–liquid extraction (SALLE) and on-line solid-phase extraction–liquid chromatography–tandem mass spectrometry (SPE–LC–MS–MS).
Photo Credit: Laguna Design/Getty Images
Scientists at the Norwegian Defence Research Establishment (Kjeller, Norway) are working in collaboration with the University of Oslo (Oslo, Norway) to develop new methods to detect the illicit use of nerve agents. In a recent study published in the journal Analytical Chemistry, the team presented a novel method for the quantification of nerve agent metabolites in human serum and urine by combining salting-out assisted liquid–liquid extraction (SALLE) and on-line solid-phase extraction–liquid chromatography–tandem mass spectrometry (SPE–LC–MS–MS).1
Nerve agents are one of the most lethal chemical warfare agents; the most commonly known are sarin, soman, tabun, GF, and VX. Belonging to the family of organophosphates, they exert their toxicity by disrupting the mechanism of nerve message transfer to organs.1 They are fairly simple to manufacture and can either be ingested, inhaled, or absorbed through the skin with lethal effect. The stockpiling and use of nerve agents is banned by the Chemical Weapons Convention, which was established by the Organization for the Prohibition of Chemical Weapons, but there are still reports of their use as a weapon. Lead author Bent Tore Røer told The Column: “The motivation for the present study was the need for a more rapid, but still sensitive method for determination of nerve agent biomarkers in serum and urine (most present developed methods require several hours of sample preparation). Rapid determination of the biomarkers is of prime importance to guide medical countermeasures in emergency cases where military personnel or civilians (for example, in terrorist actions) are exposed to nerve agents.”
On entering the body, nerve agents are broken down into different alkyl methylphosphonic acids (AMPAs) that then slowly breaks down to methylphosphonic acid (MPA). The primary metabolites can be specific to certain nerve agents, but biomarkers are rapidly excreted from the body within 1–2 weeks. Røer told The Column: “In conflicts with suspected use of chemical weapons, biological samples from survivors may not be available until several days to weeks after the incident, as was the case in the UN inspection to investigate allegations of the use of chemical weapons in Syria, 2013.”
Samples of urine and serum spiked with ethyl, isopropyl, isobutyl, cyclohexyl, and pinacolyl methylphosphinc acid were prepared using SALLE, requiring no more than 10 min sample pretreatment time. The samples were then analyzed by performing on-line hydrophilic interaction liquid chromatography (HILIC) SPE–LC–MS–MS. According to the paper, the time from receiving a sample to determining nerve agent exposure was under 30 min and the LOD was 0.04–0.12 ng/mL. Røer told The Column: “Further, the selective pre-concentration of the biomarkers on zirconium dioxide coupled on-line to LC–MS–MS gives method sensitivity comparable to the most sensitive existing method (if using a triple quadrupole MS like the others, our method would probably be the most sensitive). We believe that the combination of SALLE and on-line SPE–LC–MS–MS could be employed for many types of biomarkers, and thus has a wide application.”
Røer is now working on the write-up of his PhD thesis, but says that in the future, research will focus on using the novel combination of SALLE and on-line SPE–LC–MS–MS to determine other types of chemical warfare agents. - B.D.
Reference
1. B.T. Røen, S.R. Sellevåg, and E. Lundanes, Analytical Chemistry DOI: 10.1021/ac503408x (2014).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.